Wellington Management Group LLP Avidity Biosciences, Inc. Transaction History

Wellington Management Group LLP

$503 Billion
Q1 2025

A detailed history of Wellington Management Group LLP transactions in Avidity Biosciences, Inc. stock. As of the latest transaction made, Wellington Management Group LLP holds 9,684,556 shares of RNA stock, worth $281 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares

9,684,556

Holding current value

$281 Million

% of portfolio

0.06%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 13, 2025	BUY	$27.05 - $35.11 $262 Million - $340 Million	9,684,556 New	9,684,556 $286 Million
Q4 2024 Feb 12, 2025	BUY	$29.08 - $52.5 $31.3 Million - $56.4 Million	1,075,148 Added 15.29%	8,106,097 $236 Million
Q3 2024 Nov 14, 2024	BUY	$37.21 - $48.14 $120 Million - $155 Million	3,228,923 Added 84.93%	7,030,949 $323 Million
Q2 2024 Aug 13, 2024	BUY	$22.73 - $40.85 $58.5 Million - $105 Million	2,573,028 Added 209.36%	3,802,026 $155 Million
Q1 2024 May 15, 2024	BUY	$9.16 - $25.52 $11.3 Million - $31.4 Million	1,228,998 New	1,228,998 $31.4 Million
Q4 2023 Feb 12, 2024	BUY	$4.87 - $9.37 $1.42 Million - $2.73 Million	291,218 New	291,218 $2.64 Million
Q3 2023 Nov 14, 2023	BUY	$6.3 - $11.35 $80,860 - $145,677	12,835 Added 5.46%	248,071 $1.58 Million
Q2 2023 Aug 14, 2023	BUY	$10.62 - $17.34 $970,306 - $1.58 Million	91,366 Added 63.51%	235,236 $2.61 Million
Q1 2023 May 12, 2023	BUY	$15.35 - $25.65 $83,826 - $140,074	5,461 Added 3.95%	143,870 $2.21 Million
Q4 2022 Feb 13, 2023	SELL	$10.06 - $22.66 $602,433 - $1.36 Million	-59,884 Reduced 30.2%	138,409 $3.07 Million
Q3 2022 Nov 14, 2022	SELL	$15.46 - $23.43 $13.4 Million - $20.4 Million	-869,930 Reduced 81.44%	198,293 $3.24 Million
Q2 2022 Aug 15, 2022	SELL	$11.18 - $20.5 $754,884 - $1.38 Million	-67,521 Reduced 5.95%	1,068,223 $15.5 Million
Q1 2022 May 16, 2022	BUY	$14.2 - $23.78 $1.59 Million - $2.66 Million	112,024 Added 10.94%	1,135,744 $21 Million
Q4 2021 Feb 11, 2022	BUY	$20.4 - $28.66 $8.45 Million - $11.9 Million	414,457 Added 68.03%	1,023,720 $24.3 Million
Q3 2021 Nov 15, 2021	BUY	$18.16 - $25.21 $2.58 Million - $3.57 Million	141,807 Added 30.34%	609,263 $15 Million
Q2 2021 Aug 16, 2021	BUY	$19.62 - $29.26 $2.97 Million - $4.43 Million	151,445 Added 47.92%	467,456 $11.6 Million
Q1 2021 May 17, 2021	SELL	$20.28 - $28.15 $4.57 Million - $6.35 Million	-225,404 Reduced 41.63%	316,011 $6.89 Million
Q4 2020 Feb 12, 2021	SELL	$24.73 - $35.12 $5.11 Million - $7.26 Million	-206,692 Reduced 27.63%	541,415 $13.8 Million
Q3 2020 Nov 16, 2020	SELL	$23.35 - $35.94 $2.97 Million - $4.56 Million	-126,981 Reduced 14.51%	748,107 $21.1 Million
Q2 2020 Aug 14, 2020	BUY	$26.62 - $31.5 $23.3 Million - $27.6 Million	875,088 New	875,088 $24.7 Million

Others Institutions Holding RNA

# of Institutions

244

Shares Held

116M

Call Options Held

289K

Put Options Held

998K

View Full List

About Avidity Biosciences, Inc.

Ticker RNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,127,000
Market Cap $1.51B
Description
Avidity Biosciences, Inc., a biopharmaceutical company, engages in the development of oligonucleotide-based therapies. It develops antibody oligonucleotide conjugates (AOC) that are designed to treat a range of serious diseases. The company's lead product candidate AOC 1001 is used for the treatment of myotonic dystrophy type 1, a rare monogenic...

More about RNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wellington Management Group LLP, based on Form 13F filings with the SEC.

News

Stay updated on Wellington Management Group LLP with notifications on news.

Account

Wellington Management Group LLP Avidity Biosciences, Inc. Transaction History